NeueHealth
NEUE
NEUE was delisted on the 1st of October, 2025.
72 hedge funds and large institutions have $6.95B invested in NeueHealth in 2021 Q2 according to their latest regulatory filings, with 72 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
0.84% more ownership
Funds ownership: 0% → 0.84% (+0.84%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NMC
NEA Management Company
Timonium,
Maryland
|
+$3.74B |
| 2 |
DIC
Deer IX & Co
Larchmont,
New York
|
+$1.11B |
| 3 |
GA
Greenspring Associates
Owings Mills,
Maryland
|
+$747M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$359M |
| 5 |
Tiger Global Management
New York
|
+$203M |
Top Sellers
NEUE Hedge Fund Activity: Q2 2021 in Review
72 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in NeueHealth (NEUE) for Q2 2021, worth a combined $6.95B.
Buyers outnumbered sellers: 72 funds opened new NEUE positions and 0 closed out — a net gain of 72 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was NEA Management Company, opening a new position worth an estimated $3.74B.
- 72 institutional investors held NeueHealth (NEUE) as of Q2 2021, up from 0 in Q1 2021.
- Funds reported $6.95B of NeueHealth stock for Q2 2021.
- 72 funds opened new NeueHealth positions in Q2 2021 and 0 closed out, a net change of +72 holders.
- The largest NeueHealth buyer in Q2 2021 was NEA Management Company, an estimated $3.74B added.
Based on aggregated 13F filings for Q2 2021.